Skip to main content
placeholder image

Treatment choices impact long-term outcomes for patients with schizophrenia - what options do we currently have?

Conference Paper


Abstract


  • Due to the recent concerns over the effectiveness and safety of atypical

    antipsychotics compared with first-generation antipsychotics, prescribing of

    atypical antipsychotics continues to increase.

Publication Date


  • 2017

Citation


  • Pai, N. B. (2017). Treatment choices impact long-term outcomes for patients with schizophrenia - what options do we currently have?. Satellite Symposium - Aripiprazole- The first D2 partial agonist antipsychotic (pp. 1-1).

Start Page


  • 1

End Page


  • 1

Abstract


  • Due to the recent concerns over the effectiveness and safety of atypical

    antipsychotics compared with first-generation antipsychotics, prescribing of

    atypical antipsychotics continues to increase.

Publication Date


  • 2017

Citation


  • Pai, N. B. (2017). Treatment choices impact long-term outcomes for patients with schizophrenia - what options do we currently have?. Satellite Symposium - Aripiprazole- The first D2 partial agonist antipsychotic (pp. 1-1).

Start Page


  • 1

End Page


  • 1